Robin Wesselschmidt
About Robin Wesselschmidt
Robin Wesselschmidt serves as the Sr. Director of Clinical Product Quality at Kite Pharma, bringing extensive experience from various leadership roles in the biotechnology and pharmaceutical sectors.
Current Role at Kite Pharma
Robin Wesselschmidt serves as the Senior Director of Clinical Product Quality at Kite Pharma, a position held since 2019. In this role, Wesselschmidt is responsible for overseeing the quality assurance processes related to clinical products. Kite Pharma specializes in innovative cancer therapies, particularly in the field of cell therapy. Wesselschmidt's expertise contributes to ensuring that the clinical products meet regulatory standards and quality expectations.
Previous Experience in Clinical Management
Prior to joining Kite Pharma, Wesselschmidt held several significant positions in clinical management. From 2010 to 2012, Wesselschmidt was the Director of Program Management at City of Hope, where they managed various clinical programs. Additionally, Wesselschmidt worked at Clear Star Partners, LLC as the Principal Consultant and Founder from 2013 to 2019, providing consulting services in clinical product quality.
Educational Background in Biotechnology and Chemistry
Wesselschmidt has a strong educational foundation in the sciences. They earned a Master of Arts in Biotechnology from Washington University in St. Louis, studying from 1989 to 1992. Prior to this, Wesselschmidt obtained a Bachelor of Arts in Chemistry from the University of Missouri-Saint Louis, completing the program from 1979 to 1984. This educational background supports their extensive career in clinical product quality and management.
Career History in Biotechnology and Operations
Wesselschmidt has an extensive career in biotechnology and operations. They founded Primogenix, Inc. in 2003 and led the company until 2016. Wesselschmidt also served as the Vice President of Operations at Xenogen Corporation for one year and held the position of Director of Transgenic Technologies at Incyte from 1996 to 2001. These roles contributed to Wesselschmidt's comprehensive understanding of the biotechnology landscape.
Experience in Stem Cell Research
Wesselschmidt has significant experience in stem cell research, having worked at The Scripps Research Institute and the University of Southern California. At The Scripps Research Institute, Wesselschmidt was involved with the Stem Cell Training Center from 2007 to 2008. Prior to that, they worked at the University of Southern California's Stem Cell Core from 2005 to 2007. This experience highlights Wesselschmidt's expertise in advanced research methodologies.